Hints and tips:
...The industry faces a PR crisis; COVID-19 and big pharma’s pioneering role in providing a solution to the pandemic may be a counterbalance to these reputational issues....
...“We are playing at toy solutions at the moment,” he says....
...Recent examples include GI Partners joining Allscripts Healthcare Solutions to buy Netsmart Technologies, the healthcare software and services provider....
...Brothers and worked on transactions including Heineken and Carlsberg’s $20.2bn break-up bid for Scottish & Newcastle, Coca-Cola Hellenic’s relisting, and Misys’ $1.3bn disposal of its listed subsidiary Allscripts...
...Pre-tax profit fell 28 per cent to £32.2m as Misys faced a number of exceptional charges and fees related to the acquisition of Sophis and the disposal of Allscripts, the company’s healthcare software business...
...Misys is beginning to see signs of a return to growth in the banking sector and intends to hand the remaining £145m ($229m) proceeds from the sale of the Allscripts healthcare business back to shareholders...
...Misys, the financial software provider, is poised to acquire Irish rival Sophis for £235m with funds from the disposal of Allscripts, its healthcare arm....
...Last week Misys, the financial software provider, said it would acquire rival Sophis for £235m with funds from the disposal of its Allscripts healthcare arm....
...The group completed the disposal of most of its stake in Allscripts-Misys, its healthcare arm, for $1.2bn six weeks ahead of schedule and has pledged to return the capital to shareholders....
...As of Wednesday, Misys expects to sell most of this stake for $1.3bn in cash, as Allscripts merges with Eclipsys to create one of the largest US healthcare software ops....
...The disposal is part of a complex transaction that will see Nasdaq-listed Allscripts buy US rival Eclipsys in an all-stock deal, creating a leader in US healthcare IT....
...Today it expects to sell most of this stake for $1.3bn in cash, as Allscripts merges with Eclipsys to create one of the largest US healthcare software operations....
...Less than two years after the acquisition of a majority stake in Allscripts of the US, which Mr Lawrie promised would increase earnings per share, he plans to offload the Nasdaq-quoted healthcare software...
...Related link: Misys moves to sell Allscripts stake – FT...
...healthcare IT company....
...Misys owns 57 per cent of Allscripts, the US healthcare software company, and is expected to be a big beneficiary of the stimulus package, part of which is earmarked for helping doctors to modernise their...
...Shares in Eclipsys Corp , a healthcare information technology provider, rallied 2.8 per cent to $19.02 after Allscripts-Misys Healthcare Solutions said it would buy the company for $1.3bn....
...Earnings per share fell from 14.7p to 4.0p to reflect the shares issued to help fund the purchase of Allscripts, its US healthcare software division....
...Allscripts, its Nasdaq-listed healthcare division, has risen by almost 17 per cent this month while Misys had gained just 3.3 per cent before Monday....
...An improving outlook in banking would increase scrutiny on an apparent valuation gap between Misys and Allscripts, the group’s US healthcare subsidiary....
...The acquisition of US healthcare software group Allscripts attracted criticism because it pushed the group further into debt....
...Full-year results were in line with reduced market expectations and were boosted by the inclusion of US healthcare group Allscripts, the centrepiece of chief executive Mike Lawrie’s turnround plan....
...Mike Lawrie, chief executive, has made Allscripts-Misys central to his planned three- to five-year turnround, begun in 2006....
...And technology will be part of the solution. “It isn’t about a new x-ray machine that can analyse you down to the molecular level....
...Emerging markets are robust and the merger with Allscripts gives it the scale to attack the fragmented US healthcare market....
International Edition